-
Summary The Laboratory Director will oversee day to day operation of the NMR and Drug Metabolism Core, an Institutional Advanced Technology Core (ATC). The main duties will be the direct management
-
of neurodevelopmental and neuropsychiatric conditions using cutting-edge proximity proteomics, protein engineering, CRISPR genome engineering, computational structural biology, and high-throughput electrophysiological
-
clinical staff in the EMU. Minimum Qualifications High School diploma or GED. Three years of relevant experience. Preferred Qualifications Bachelor's degree in neuroscience or cognitive science, engineering
-
engineered mouse models (GEMMs). We are actively seeking a highly motivated Postdoctoral Associate who shares our passion for translational tumor research. For further insight into our work, please consider
-
experience. Preferred Qualifications Preference given to those with a Bachelor's degree and /or 1st Grade Stationary Engineer's license. Baylor College of Medicine is an Equal Opportunity/Affirmative Action
-
Center at Baylor College of Medicine is seeking a highly motivated and skilled research scientist to join our team, focusing on mass spectrometry-based immunopeptidomics technology and its applications in
-
, genetics, or physiology Good organizational skills, excellent record keeping, attention to detail, and the ability to work well with others Experience handling and working with genetically engineered lab
-
Apply now » Title: Laboratory Director Division: Advanced Technology Cores Schedule: Monday – Friday, 8 a.m. – 5 p.m. Work Location: Houston, TX Salary Range: $92,000 - $105,000 FLSA Status: Exempt
-
for engineering microbial platforms to sense disease biomarkers in the human body and produce therapeutic proteins in the gut environment. The ability to grow human intestinal communities under physiological
-
cancer and their survival, development of improved technology to identity extracellular platelet phosphatase in the tumor microenvironment and large-scale analysis and validation of platelet phosphatase in